Competition Committee warns public against misleading supplement advertisements

According to the committee, it regularly conducts test purchases of food products, medicines, and dietary supplements to monitor quality and compliance. In 2023, 24 out of 397 inspected products failed to meet quality standards; in 2024, 95 out of 560 did not comply; and in the first nine months of 2025, 123 out of 618 were found to be substandard.

The committee also reported receiving more than 2,345 citizen appeals related to these products, of which 337 (14%) concerned dietary and food supplements. Most complaints were linked to products that were heavily advertised as “miracle cures” but did not deliver results or caused harm to users’ health.

The regulator cautioned the public against misleading marketing slogans such as “we can cure all diseases in one month.”

“Dietary supplements are not medicines and are not intended to treat diseases. They may only be used to support bodily functions or to help prevent certain illnesses,” the committee said in its statement.

The Competition Committee urged consumers to prioritize their health by purchasing only officially registered and certified products approved by the Ministry of Health. It also emphasized the importance of consulting a doctor before using any supplements.